Takeda's Orteronel (TAK-700) Enters Phase III Clinical Trials For Prostate Cancer – Asian Scientist Magazine
Asian Scientist MagazineTakeda's Orteronel (TAK-700) Enters Phase III Clinical Trials For Prostate CancerAsian Scientist MagazineThe first (C21004) is a randomized, double-blind and multi-center trial of prednisolone plus orteronel or placebo in pa…